Today, treatment for many congenital heart diseases is possible. Treatment options are determined by the type of anomaly, gestational age, co-occurring major anomalies, and ethical considerations. The detection of congenital heart diseases via fetal echocardiography allows for a comprehensive assessment based on the specific characteristics of the pathology. In such cases, prenatal and postnatal follow-up of the mother and baby is of great importance. Parents are directed to appropriate specialized centers to ensure that necessary medical intervention at birth can be performed optimally. This approach ensures the planning of early and accurate treatment for the baby.

During fetal echocardiography screenings, for babies diagnosed with severe heart disease, families are provided with detailed information about the option of terminating the pregnancy up to the 24th week of gestation. Furthermore, when fetal rhythm disturbances are detected, appropriate drug treatments administered to the mother help regulate the baby's heart rhythm.